325 related articles for article (PubMed ID: 25713800)
21. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
22. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
Kaneko M; Futamura Y; Tsukuda S; Kondoh Y; Sekine T; Hirano H; Fukano K; Ohashi H; Saso W; Morishita R; Matsunaga S; Kawai F; Ryo A; Park SY; Suzuki R; Aizaki H; Ohtani N; Sureau C; Wakita T; Osada H; Watashi K
Sci Rep; 2018 Feb; 8(1):2769. PubMed ID: 29426822
[TBL] [Abstract][Full Text] [Related]
23. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
24. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B Surface Antigen Activates Unfolded Protein Response in Forming Ground Glass Hepatocytes of Chronic Hepatitis B.
Li Y; Xia Y; Cheng X; Kleiner DE; Hewitt SM; Sproch J; Li T; Zhuang H; Liang TJ
Viruses; 2019 Apr; 11(4):. PubMed ID: 31027244
[TBL] [Abstract][Full Text] [Related]
26. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
27. Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes.
Fukano K; Tsukuda S; Oshima M; Suzuki R; Aizaki H; Ohki M; Park SY; Muramatsu M; Wakita T; Sureau C; Ogasawara Y; Watashi K
Front Microbiol; 2018; 9():3257. PubMed ID: 30671048
[TBL] [Abstract][Full Text] [Related]
28. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
[TBL] [Abstract][Full Text] [Related]
29. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
Elife; 2012 Nov; 3():. PubMed ID: 25409679
[TBL] [Abstract][Full Text] [Related]
30. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
31. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
Li J; Tong S
Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
[TBL] [Abstract][Full Text] [Related]
32. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
33. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
Fu L; Hu H; Liu Y; Jing Z; Li W
Virology; 2017 May; 505():1-11. PubMed ID: 28213271
[TBL] [Abstract][Full Text] [Related]
34. Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
Veloso Alves Pereira I; Buchmann B; Sandmann L; Sprinzl K; Schlaphoff V; Döhner K; Vondran F; Sarrazin C; Manns MP; Pinto Marques Souza de Oliveira C; Sodeik B; Ciesek S; von Hahn T
PLoS One; 2015; 10(2):e0117152. PubMed ID: 25646622
[TBL] [Abstract][Full Text] [Related]
35. Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus Production.
Inoue J; Ninomiya M; Umetsu T; Nakamura T; Kogure T; Kakazu E; Iwata T; Takai S; Sano A; Fukuda M; Watashi K; Isogawa M; Tanaka Y; Shimosegawa T; McNiven MA; Masamune A
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118260
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
37. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M
Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527
[TBL] [Abstract][Full Text] [Related]
39. Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma.
Wang P; Mo R; Lai R; Xu Y; Lu J; Zhao G; Liu Y; Cao Z; Wang X; Li Z; Lin L; Zhou H; Cai W; Wang H; Bao S; Xiang X; Xie Q
Oncotarget; 2017 Dec; 8(62):105407-105424. PubMed ID: 29285260
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of hepatitis B virus attachment and entry.
Lempp FA; Urban S
Intervirology; 2014; 57(3-4):151-7. PubMed ID: 25034482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
